透過您的圖書館登入
IP:18.226.251.68
  • 學位論文

大鼠體內L-3-羥基丁酸之分析及其在心臟之作用

Determination of L-3-Hydroxybutyrate in rats and its effects on rat heart

指導教授 : 李仁愛
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


D-3-Hydroxybutyrate(D-3HB)為體內之ketone bodies中含量最高者,且被作為研究ketone bodies之作用的主要目標。相反地,一般認為L-3-hydroxybutyrate(L-3HB)並非生物體內源生之ketone body,或許是基於其尚有爭議的代謝途徑;以及目前不瞭解其生成來源。在本論文中以螢光衍生化法搭配High-Performance Liquid Chromatography(HPLC)所開發之分析方法已能證實rat serum中的確有L-3HB的存在。Serum中之total 3HB經NBD-PZ衍生化後先經由一ODS column將之分離,隨後以兩支CHIRALCEL OD-RH串聯之chiral columns進行chiral separation。Rat serum並以D-3-hydroxybutyryl dehydrogenase處理作為對照組,以驗證所分離之3HB的真實性。實驗結果顯示serum中含有L-3HB,其與D-3HB的濃度分別為3.98(3.61%)與106.20 ?M(96.39%)。在以此分析方法成功地證實L-3HB存在後,我們再進一步應用於rat體內各組織中D-與L-3HB的分佈情形。 分取rat之腦、肝、心、及腎的研磨後均質液,經分析後發現heart中含有特殊高量的L-3HB;為所有檢測的組織中最特別者。D/L-3HB之比例在正常與diabetes mellitus(DM)時有所不同,其比例(D/L)分別為66/37與87/13。此變化可能是造成glucose代謝能力受影響的原因之一。當投予5 mM 之D-3HB於medium中,cardiomyocytes的glucose代謝會降低至控制組的61%,但給予同等劑量之L-3HB並未對細胞之glucose代謝造成任何影響,此結果反映著L-3HB與其他ketone bodies不同;並非作為提供能量的物質。此外,D-3HB抑制glucose代謝的作用可被另行添加之L-3HB阻斷;且L-3HB回復glucose代謝的作用會隨著其濃度增加而升高。藉由測量cardiomyocytes代謝D-、L-、與(D+L)-3HB能力的結果發現,D-與L-3HB同時存在的情況下反而會加速D-3HB的代謝;且可發現L-3HB的生成。由此推測L-3HB會刺激D-3HB進行interconversion生成L-3HB;使D-3HB的代謝不再回復產生acetyl CoA。實驗結果顯示L-3HB有別於D-3HB,為維持正常glucose utilization的重要物質,其可能在ketone bodies與glucose的代謝之間扮演著調節的角色。

並列摘要


While D-3-Hydroxybutyrate (D-3HB) is usually the major ketone body which was under intensive investigation, little attention had been paid to L-3-hydroxybutyrate (L-3HB). It had been considered nonexistent physiologically, perhaps due to its dubious metabolic route and lack of knowledge about its origin. In the present study, we proved that L-3HB is an original substance in rat serum by applying fluorescence derivatization and a column-switching high-performance liquid chromatography (HPLC) system as the analysis technique. Total 3HB in rat serum derivatized by 4-nitro-7-piperazino-2,1,3-benzoxadiazole (NBD-PZ) was separated by an ODS column, and was confirmed by verifying the disappearance of the total 3HB peak after pretreating rat serum with D-3-hydroxybutyryl dehydrogenase (D-3HB dehydrogenase). A switching valve was used to simultaneously introduce isolated (D+L)-3HB to the enantiomeric separation by two CHIRALCEL OD-RH columns connected in tandem. An L-isomer was found to accompany the D-isomer, which were quantified to be 3.98 (3.61%) and 106.20 ?M (96.39%), respectively. Using the present analytical method, the dubious interpretation of the existence of L-3HB was clarified. Subsequently, distribution of D- and L-3HB in rat brain, liver, heart, and kidney homogenates were measured. The results showed that an enriched amount of L-3HB is present in rat hearts. The ratio would be changed from 66/34 to 87/13 (D/L) in normal and diabetic states, respectively. The altered D/L ratio may contribute to the reduction in glucose utilization by cardiomyocytes. Glucose utilization of cardiomyocytes with 5 mM of D-3HB was decreased to 61% of the control, but no interfering was observed when D-3HB was replaced with L-3HB, suggesting L-3HB is not utilized as the energy fuel as other ketone bodies are. In addition, the reduced glucose utilization caused by D-3HB could gradually recover in a dose-dependent manner with administration of additional L-3HB. Determination on metabolism of D-, L-, and (D+L)-3HB by cardiomyocytes showed cells had increased D-3HB metabolism when (D+L)-3HB was administered, and re-generation of L-3HB was found under the circumstance. It was speculated that in the presence of L-3HB, D-3HB might go through interconversion to generate L-3HB rather than being oxidized to acetyl CoA. The results suggest that it is a necessity of taking L-3HB together with D-3HB when it comes to glucose utilization. A physiological role is proposed for L-3HB as an important substrate which regulates the metabolism between glucose and ketone bodies.

參考文獻


2. Laffel L: Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes/metabolism research and reviews 15:412-426, 1999
3. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL: D-?-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 97:5440-5444, 2000
4. Greene AE, Todorova MT, Seyfried TN: Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. Journal of Neurochemistry 86:529-537, 2003
5. Zou Z, Sasaguri S, Rajesh KG, Suzuki R: dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. American Journal of Physiology - Heart & Circulatory Physiology 283:H1968-1974, 2002
6. Oshida Y, Iwao N, Ohsawa I, Sato J, Nakao T, Sato Y: Effect of insulin on intramuscular 3-hydroxybutyrate levels in diabetic rats. Hormone & Metabolic Research 30:70-71, 1998

延伸閱讀